Explore more publications!

Sci-Tech Today Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today Bhutan.

Press releases published on April 13, 2026

Zoonova AI Launches Alpha AI, Bringing Quant-Driven Analytics to Everyday Investors
A Grand Event for the Rubber and Plastics Industry — CYCJET Joins You at Chinaplas 2026
Un gran evento para la industria del caucho y el plástico: CYCJET lo invita a Chinaplas 2026
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene annonce la fin de la randomisation des patients de la partie Phase 2 de l’essai clinique évaluant TG4050 dans le traitement adjuvant des cancers de la tête et du cou
SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants
WISeSat et le Commandement de l’Espace des Forces armées suisses finalisent la phase pilote et préparent la mission de nouvelle génération WISeSat 6U prévue pour novembre 2026
WISeSat and Swiss Space Command of the Swiss Armed Forces Complete Pilot Phase and Prepare Next-Generation WISeSat 6U Mission Planned for November 2026
WISeSat et le Commandement de l’Espace des Forces armées suisses finalisent la phase pilote et préparent la mission de nouvelle génération WISeSat 6U prévue pour novembre 2026
Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
Bitcoin Poker No Deposit Bonus 2026: BC Poker Offers $10 Free to Play Online Poker for Real Money With No Cashout Cap, Provably Fair Tables, and Instant Crypto Withdrawals

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions